Business Context and Reporting Period
Maiden Holdings, Ltd. (MHLD), a Bermuda-based holding company, filed this Form 8-K on November 13, 2020, to report its financial results for the three and nine months ended September 30, 2020. The company is currently in a run-off phase for its reinsurance liabilities following the termination of major quota share agreements in 2019. The filing also announces the commencement of a cash tender offer to repurchase specific series of preference shares.
Key Financial Metrics
Quarter Ended September 30, 2020
- Net Income: $2.2 million ($0.03 per diluted common share), compared to a net loss of $58.3 million in Q3 2019.
- Non-GAAP Operating Loss: $2.3 million ($0.03 per share).
- Underwriting Income: $3.4 million, a significant improvement from an underwriting loss of $80.3 million in Q3 2019.
- Net Premiums Written: $3.0 million, down from $35.9 million in Q3 2019.
- Net Investment Income: $12.7 million.
- Book Value per Common Share: $0.86 (up from $0.51 at year-end 2019).
- Adjusted Book Value per Common Share: $1.81 (includes $80.0 million unamortized deferred gain on retroactive reinsurance).
Nine Months Ended September 30, 2020
- Net Income: $32.2 million ($0.38 per diluted common share), compared to a net loss of $110.4 million in the same period in 2019.
- Non-GAAP Operating Earnings: $2.0 million ($0.02 per share).
- Underwriting Loss: $0.3 million, improved from a loss of $162.1 million in the prior year period.
- Total Assets: $3.1 billion (down from $3.6 billion at year-end 2019).
- Shareholders' Equity: $538.1 million.
- Debt: Senior notes principal amount of $262.5 million.
Material Changes vs. Prior Period
The dramatic improvement in net income from a loss in 2019 to profitability in 2020 is primarily driven by:
- Loss Development: Favorable prior year loss development of $7.2 million in Q3 2020, compared to adverse development of $63.2 million in Q3 2019. For the nine months, favorable development was $7.8 million versus adverse $96.5 million in 2019.
- Termination of Agreements: The cessation of the AmTrust Reinsurance quota share agreements effective January 1, 2019, significantly reduced exposure to large losses and lowered net premiums written.
- Expense Reduction: Commission and acquisition expenses decreased by 70.5% in Q3 and 80.4% for the nine months, reflecting lower earned premiums. General and administrative expenses also declined due to ongoing cost-cutting measures.
- Investment Results: Realized investment gains were lower in Q3 2020 ($4.1 million) compared to Q3 2019 ($12.7 million), partially offsetting underwriting improvements.
Guidance, Outlook, and Material Events
Tender Offer for Preference Shares
Maiden announced a cash tender offer to purchase up to $100 million of its Series A, Series C, and Series D preference shares at $10.50 per share. The offer is intended to adjust the capital structure to reflect current operations and enhance value for common shareholders. The offer expires on December 15, 2020.
Management Commentary and Outlook
- Strategy: Management continues to focus on asset and capital management strategies while running off reinsurance liabilities. Active underwriting is viewed as presenting limited opportunities in the current environment.
- Loss Trends: While multiple quarters of stabilization in loss experience are encouraging, management notes that the run-off portfolio requires additional maturity to fully emerge.
- Dividends: The Board did not authorize any quarterly dividends for common or preference shares.
- COVID-19: The company reports immaterial impacts from the pandemic on operations to date.
Investor Verification Checklist
- Verify the terms and acceptance rates of the $100 million preference share tender offer.
- Review the sustainability of favorable loss development trends in the run-off portfolio.
- Monitor the amortization schedule of the $80.0 million unamortized deferred gain on retroactive reinsurance.
- Assess the impact of declining investable assets on future investment income yields.
- Confirm the status of the Strategic Review and any further headcount or expense reductions.